Previous 10 | Next 10 |
— Findings From Qualitative Patient Substudy Evaluating Health-Related Quality of Life in Patients With Schizophrenia and Treatment Satisfaction, Including Treatment with ALKS 3831, to be Presented — DUBLIN , May 27, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS...
-- Phase 3b Study Evaluated Efficacy and Safety of ARISTADA ® 2-month Dose, Together With ARISTADA INITIO ® One-day Initiation Regimen, in Patients Hospitalized for Acute Schizophrenia -- DUBLIN , May 20, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS...
-- E-Poster Presentations Include Results From Completed 52-Week, Open-Label Safety Study of ALKS 3831 in Patients With Schizophrenia -- DUBLIN , May 14, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the presentation of new data from its schizophreni...
-- Retail Pharmacies, Including 900 Albertsons Locations, Added to the Provider Locator to Provide Injections of ARISTADA and VIVITROL; Additional Programs In Place to Deliver Support and Financial Assistance -- DUBLIN , May 11, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS)...
DUBLIN , May 6, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the 2020 Bank of America Securities Virtual Health Care Conference on Wednesday, May 13, 2020 at 9:40 a.m. ET ( 2:40 p.m. B...
DUBLIN , May 4, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that the company is now accepting applications for its newly-established COVID-19 Relief Fund, a special edition of the company's signature Alkermes Inspiration Grants ® program. The company ha...
Image source: The Motley Fool. Alkermes PLC (NASDAQ: ALKS) Q1 2020 Earnings Call Apr 29, 2020 , 8:00 a.m. ET Operator Continue reading
Alkermes plc (ALKS) Q1 2020 Results Earnings Conference Call April 29, 2020, 08:00 AM ET Company Participants Sandra Coombs - Vice President, Investor Relations Richard Pops - Chairman and Chief Executive Officer Todd Nichols - Senior Vice President, Sales and Marketing James F...
The following slide deck was published by Alkermes plc in conjunction with their 2020 Q1 earnings Read more ...
Alkermes ( ALKS ) Q1 results : More news on: Alkermes plc, Healthcare stocks news, Earnings news and commentary, Read more ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-22 10:45:03 ET Enbridge Inc (ENB) ENB is trading UP for the last 5 days, and it at trading at $36.59 with volume of 731,965 and a one day change of $0.05 (0.14%). Enbridge Inc has a 52-week low of 31.03 and a 52-week high of $38.36. The business's 50-day moving average price...
Alkermes to Report Second Quarter Financial Results on July 24, 2024 PR Newswire DUBLIN , July 17, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET ( 1:00 p.m. BST ) on Wednesday, ...
2024-06-29 16:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...